Overview

Quetiapine for the Reduction of Cocaine Use

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This placebo-controlled trial will test the effectiveness of Seroquel XR™ for the treatment of cocaine dependence in non-psychotic individuals who are cocaine dependent.
Phase:
N/A
Details
Lead Sponsor:
Seattle Institute for Biomedical and Clinical Research
Collaborators:
AstraZeneca
VA Puget Sound Health Care System
Treatments:
Cocaine
Quetiapine Fumarate